These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8533017)
21. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB; Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617 [TBL] [Abstract][Full Text] [Related]
22. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists]. Carme B; Péguet C; Nevez G Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468 [TBL] [Abstract][Full Text] [Related]
23. Effects of cimetidine on the pharmacokinetics of proguanil in healthy subjects and in peptic ulcer patients. Kolawole JA; Mustapha A; Abdul-Aguye I; Ochekpe N; Taylor RB J Pharm Biomed Anal; 1999 Sep; 20(5):737-43. PubMed ID: 10701981 [TBL] [Abstract][Full Text] [Related]
24. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Obua C; Ntale M; Lundblad MS; Mahindi M; Gustafsson LL; Ogwal-Okeng JW; Anokbonggo WW; Hellgren U Afr Health Sci; 2006 Jun; 6(2):86-92. PubMed ID: 16916298 [TBL] [Abstract][Full Text] [Related]
27. [Chemoprophylaxis of Plasmodium falciparum malaria by a combination of 100 mg of chloroquine and 200 mg of proguanil per day in a zone III of chloroquine resistance (Gabon). Study of 431 French soldiers]. Sarrouy J; Cellier C; Migliani R; Todesco A; Favier G; Linden L; Pull J; Pascal B; Baudon D; Delolme H Bull Soc Pathol Exot; 1991; 84(1):80-93. PubMed ID: 2065406 [TBL] [Abstract][Full Text] [Related]
28. Malaria chemoprophylaxis with atovaquone-proguanil: is a shorter regimen fully protective? Grobusch MP J Travel Med; 2014; 21(2):79-81. PubMed ID: 24593022 [No Abstract] [Full Text] [Related]
29. Malaria chemosuppression in pregnancy. I. The effect of chemosuppressive drugs on maternal parasitaemia. Mutabingwa TK; Malle LN; de Geus A; Oosting J Trop Geogr Med; 1993 Mar; 45(1):6-14. PubMed ID: 8470311 [TBL] [Abstract][Full Text] [Related]
30. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Watkins WM; Mberu EK; Nevill CG; Ward SA; Breckenridge AM; Koech DK Trans R Soc Trop Med Hyg; 1990; 84(4):492-5. PubMed ID: 2091335 [TBL] [Abstract][Full Text] [Related]
31. Comparison of three malaria chemoprophylactic regimens in residents in east, central and southern Africa. A prospective, randomized multicentre trial in The Netherlands. Wetsteyn JC; de Geus A Trop Geogr Med; 1995; 47(3):103-6. PubMed ID: 7482998 [TBL] [Abstract][Full Text] [Related]
32. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz. Soyinka JO; Onyeji CO Eur J Pharm Sci; 2010 Feb; 39(4):213-8. PubMed ID: 19961932 [TBL] [Abstract][Full Text] [Related]
33. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546 [TBL] [Abstract][Full Text] [Related]
34. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239 [TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of atovaquone and proguanil hydrochloride. Beerahee M J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547 [TBL] [Abstract][Full Text] [Related]
36. Human pharmacokinetics of proguanil and its metabolites. Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140 [TBL] [Abstract][Full Text] [Related]
37. Antimalarial chemoprophylaxis in a deployed Naval Unit. Terry MC; Heames RM J R Nav Med Serv; 2011; 97(2):59-61. PubMed ID: 22013637 [No Abstract] [Full Text] [Related]
38. Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound. Helsby NA; Ward SA; Parslew RA; Friedmann PS; Rhodes LE Acta Derm Venereol; 1998 Mar; 78(2):81-3. PubMed ID: 9534880 [TBL] [Abstract][Full Text] [Related]
39. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669 [TBL] [Abstract][Full Text] [Related]
40. Dose Optimization of Chloroquine by Pharmacokinetic Modeling During Pregnancy for the Treatment of Zika Virus Infection. Olafuyi O; Badhan RKS J Pharm Sci; 2019 Jan; 108(1):661-673. PubMed ID: 30399360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]